CD366 (TIM-3) Antibody, anti-human, REAlease®
Synonyms: HAVcr-2, TIMD-3
RECOMBINANT EXTENDED VALIDATION
Clone:
REAL226
Type of antibody:
Releasable antibodies, Primary antibodies, Recombinant antibodies
Applications:
FC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for CD366 (TIM-3) Antibody, anti-human, REAlease®

Flow cytometry applications
APC
PE
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-125-770, 130-125-775
Description:
Human peripheral blood mononuclear cells (PBMCs), either left unstimulated or stimulated with CD3/CD28 antibodies for 3 days, were stained with REAlease CD366 (TIM-3) REAlease Complexes or with the corresponding REAL Control (left images) as well as with CD3 and CD4 (VIT-4) antibodies and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide (PI) fluorescence.

Application imageView details view details

Application imageView details view details
Extended validation for CD366 (TIM-3) Antibody, anti-human, REAlease®
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REAL226
2321C
low
7D3
low
F38-2E2
high
REA635
high

Cells were incubated with an excess of purified unconjugated CD366 (TIM-3) (REAL226) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.

Specifications for CD366 (TIM-3) Antibody, anti-human, REAlease®
Overview

Clone REAL226 is an antibody fragment derived from the full CD366 (TIM-3) antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAlease Complex to bind markers with high avidity.

Clone REAL226 recognizes the human CD366 antigen, a single-pass type I membrane protein which is also known as T cell immunoglobulin and mucin domain containing protein-3 (TIM-3) or Hepatitis A virus cellular receptor 2 (HAVcr-2). CD366 is expressed on activated T cells, especially Tʜ1 cells, monocytes, macrophages, and dendritic cells. It is an activation-induced inhibitory molecule involved in tolerance and shown to induce T cell exhaustion in chronic viral infection and cancers. CD366 has been proposed to inhibit Tʜ1-mediated immune responses and regulates Tʜ1 and Tʜ17 cytokine secretion. The interaction of CD366 and its ligand galectin-9 induces apoptosis of Tʜ1 cells.

The REAlease Kits consist of the respective fluorochrome-conjugated REAlease Complexes and the REAlease Support Kit for removal of the REAlease Complexes and optional relabeling with different fluorochrome-conjugated REAlease Complexes.

Alternative names

HAVcr-2, TIMD-3

Detailed product information

Technical specifications

Clone
REAL226
Clonality
monoclonal
Isotype control
Control Antibody
Host
cell line
Type of antibody
Releasable antibodies, Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
CD366 (TIM-3)
Distribution of antigen
dendritic cells, macrophages, monocytes, T cells
RRID
AB_2751534, AB_2751545, AB_2857791, AB_2857788, AB_2784167
Resources for CD366 (TIM-3) Antibody, anti-human, REAlease®
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?